Delivery of exogenous antigens to induce cytotoxic CD8+ T lymphocyte responses

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Kim, Julia ^a   Gambhir, Vandana ^a   Alatery, Attiya ^a   Basta, Sameh ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARCHAEOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICROSPHERE; UNCLASSIFIED DRUG; VACCINE;

ANTIGEN PRESENTATION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEX FORMATION; CROSS PRESENTATION; DRUG EFFICACY; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; MEMORY T LYMPHOCYTE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION; VIRUS LIKE AGENT;

EID: 77953481373     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/218752     Document Type: Review

References (93)

1. Shresta S., Pham C. T., Thomas D. A., Graubert T. A., Ley T. J., How do cytotoxic lymphocytes kill their targets? Current Opinion in Immunology 1998 10 5 581 587
2. Melief C. J. M., Kast W. M., Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms Seminars in Cancer Biology 1991 2 5 347 354
3. Harty J. T., Schreiber R. D., Bevan M. J., CD8 T cells can protect against an intracellular bacterium in an interferon -independent fashion Proceedings of the National Academy of Sciences of the United States of America 1992 89 23 11612 11616
4. Basta S., Alatery A., The cross-priming pathway: a portrait of an intricate immune system Scandinavian Journal of Immunology 2007 65 4 311 319
5. Heath W. R., Belz G. T., Behrens G. M. N., Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens Immunological Reviews 2004 199 9 26
6. Yewdell J. W., Haeryfar S. M. M., Understanding presentation of viral antigens to CD 8+ T cells in vivo: the key to rational vaccine design Annual Review of Immunology 2005 23 651 682
7. Shen L., Rock K. L., Priming of T cells by exogenous antigen cross-presented on MHC class I molecules Current Opinion in Immunology 2006 18 1 85 91
8. Basta S., Bennink J. R., A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways Viral Immunology 2003 16 3 231 242
9. van der Most R. G., Currie A., Robinson B. W. S., Lake R. A., Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity Cancer Research 2006 66 2 601 604
10. Sharpe A. H., Mechanisms of costimulation Immunological Reviews 2009 229 1 5 11
11. Valenzuela J., Schmidt C., Mescher M. F., The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells The Journal of Immunology 2002 169 12 6842 6849
12. Curtsinger J. M., Valenzuela J. O., Agarwal P., Lins D., Mescher M. F., Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation The Journal of Immunology 2005 174 8 4465 4469
13. Mescher M. F., Agarwal P., Casey K. A., Hammerbeck C. D., Xiao Z., Curtsinger J. M., Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation Seminars in Immunology 2007 19 3 153 161
14. Xiao Z., Casey K. A., Jameson S. C., Curtsinger J. M., Mescher M. F., Programming for CD8 T cell memory development requires IL-120 or type I IFN The Journal of Immunology 2009 182 5 2786 2794
15. Rock K. L., York I. A., Saric T., Goldberg A. L., Protein degradation and the generation of MHC class I-presented peptides Advances in Immunology 2002 80 1 70
16. Yewdell J. W., Reits E., Neefjes J., Making sense of mass destruction: quantitating MHC class I antigen presentation Nature Reviews Immunology 2003 3 12 952 961
17. Basta S., Stoessel R., Basler M., van den Broek M., Groettrup M., Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins The Journal of Immunology 2005 175 2 796 805
18. Fonteneau J. F., Kavanagh D. G., Lirvall M., Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells Blood 2003 102 13 4448 4455
19. Carbone F. R., Bevan M. J., Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo Journal of Experimental Medicine 1990 171 2 377 387
20. Pfeifer J. D., Wick M. J., Roberts R. L., Findlay K., Normark S. J., Harding C. V., Phagocytic processing of bacterial antigens for class I MHC presentation to T cells Nature 1993 361 6410 359 362
21. Chen W., Masterman K.-A., Basta S., Cross-priming of CD 8+ T cells by viral and tumor antigens is a robust phenomenon European Journal of Immunology 2004 34 1 194 199
22. Shimizu K., Kurosawa Y., Taniguchi M., Steinman R. M., Fujii S.-I., Cross-presentation of glycolipid from tumor cells loaded with -galactosylceramide leads to potent and long-lived T cell-mediated immunity via dendritic cells Journal of Experimental Medicine 2007 204 11 2641 2653
23. Li Y., Wang L.-X., Pang P., Cross-presentation of tumor associated antigens through tumor-derived autophagosomes Autophagy 2009 5 4 576 577
24. Basta S., Chen W., Bennink J. R., Yewdell J. W., Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD 8+ T cells The Journal of Immunology 2002 168 11 5403 5408
25. Serna A., Ramirez M. C., Soukhanova A., Sigal L. J., Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells The Journal of Immunology 2003 171 11 5668 5672
26. Schulz O., Diebold S. S., Chen M., Toll-like receptor 3 promotes cross-priming to virus-infected cells Nature 2005 433 7028 887 892
27. Goldszmid R. S., Coppens I., Lev A., Caspar P., Mellman I., Sher A., Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii -infected dendritic cells Journal of Experimental Medicine 2009 206 2 399 410
28. Norbury C. C., Basta S., Donohue K. B., CD 8+ T cell cross-priming via transfer of proteasome substrates Science 2004 304 5675 1318 1321
29. Shen L., Rock K. L., Cellular protein is the source of cross-priming antigen in vivo Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 3035 3040
30. Bins A. D., Wolkers M. C., van den Boom M. D., Haanen J. B. A. G., Schumacher T. N. M., In vivo antigen stability affects DNA vaccine immunogenicity The Journal of Immunology 2007 179 4 2126 2133
31. Wolkers M. C., Brouwenstijn N., Bakker A. H., Toebes M., Schumacher T. N. M., Antigen bias in T cell cross-priming Science 2004 304 5675 1314 1317
32. Li M., Davey G. M., Sutherland R. M., Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo The Journal of Immunology 2001 166 10 6099 6103
33. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K. L., Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages Proceedings of the National Academy of Sciences of the United States of America 1993 90 11 4942 4946
34. Sigal L. J., Rock K. L., Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation Journal of Experimental Medicine 2000 192 8 1143 1150
35. Sigal L. J., Crotty S., Andino R., Rock K. L., Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen Nature 1999 398 6722 77 80
36. Huang A. Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H., Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses Ciba Foundation Symposium 1994 187 229 244
37. Alatery A., Siddiqui S., Chan M., Kus A., Petrof E. O., Basta S., Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state Immunology and Cell Biology 2010 88 1 3 12
38. Ackerman A. L., Cresswell P., Cellular mechanisms governing cross-presentation of exogenous antigens Nature Immunology 2004 5 7 678 684
39. Burgdorf S., Scholz C., Kautz A., Tampe R., Kurts C., Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation Nature Immunology 2008 9 5 558 566
40. Kurts C., Kosaka H., Carbone F. R., Miller J. F. A. P., Heath W. R., Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD 8+ T cells Journal of Experimental Medicine 1997 186 2 239 245
41. Limmer A., Ohl J., Kurts C., Efficient presentation of exogenous antigen by liver endothelial cells to CD 8+ T cells results in antigen-specific T-cell tolerance Nature Medicine 2000 6 12 1348 1354
42. Schildknecht A., Probst H. C., McCoy K. D., Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD 8+ T cells European Journal of Immunology 2009 39 6 1505 1515
43. Lutz M. B., Kurts C., Induction of peripheral CD 4+ T-cell tolerance and CD 8+ T-cell cross-tolerance by dendritic cells European Journal of Immunology 2009 39 9 2325 2330
44. Redmond W. L., Wei C.-H., Kreuwel H. T. C., Sherman L. A., The apoptotic pathway contributing to the deletion of naive CD8 T cells during the induction of peripheral tolerance to a cross-presented self-antigen The Journal of Immunology 2008 180 8 5275 5282
45. Limmer A., Ohl J., Wingender G., Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance European Journal of Immunology 2005 35 10 2970 2981
46. Mellman I., Steinman R. M., Dendritic cells: specialized and regulated antigen processing machines Cell 2001 106 3 255 258
47. Northrop J. K., Shen H., CD 8+ T-cell memory: only the good ones last Current Opinion in Immunology 2004 16 4 451 455
48. Esser M. T., Marchese R. D., Kierstead L. S., Memory T cells and vaccines Vaccine 2003 21 5-6 419 430
49. Yewdell J. W., Confronting complexity: real-world immunodominance in antiviral CD 8+ T cell responses Immunity 2006 25 4 533 543
50. Dunbar E., Alatery A., Basta S., Cross-priming of a single viral protein from lymphocytic choriomeningitis virus alters immunodominance hierarchies of CD 8+ T cells during subsequent viral infections Viral Immunology 2007 20 4 585 598
51. Pavelic V., Matter M., Mumprecht S., Breyer I., Ochsenbein A. F., CTL induction by cross-priming is restricted to immunodominant epitopes European Journal of Immunology 2009 39 3 704 716
52. Otahal P., Hutchinson S. C., Mylin L. M., Tevethia M. J., Tevethia S. S., Schell T. D., Inefficient cross-presentation limits the CD 8+ T cell response to a subdominant tumor antigen epitope The Journal of Immunology 2005 175 2 700 712
53. Wang Y., Flesch I. E. A., Tscharke D. C., Vaccinia virus CD 8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides Journal of Virology 2009 83 17 9008 9012
54. Heit A., Busch D. H., Wagner H., Schmitz F., Vaccine protocols for enhanced immunogenicity of exogenous antigens International Journal of Medical Microbiology 2008 298 1-2 27 32
55. Heit A., Schmitz F., O'Keeffe M., Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines The Journal of Immunology 2005 174 7 4373 4380
56. Zaks K., Jordan M., Guth A., Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes The Journal of Immunology 2006 176 12 7335 7345
57. Hervas-Stubbs S., Olivier A., Boisgerault F., Thieblemont N., Leclerc C., TLR3 ligand stimulates fully functional memory CD 8+ T cells in the absence of CD 4+ T-cell help Blood 2007 109 12 5318 5326
58. Heit A., Maurer T., Hochrein H., Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells The Journal of Immunology 2003 170 6 2802 2805
59. Heit A., Huster K. M., Schmitz F., Schiemann M., Busch D. H., Wagner H., CpG-DNA aided cross-priming by cross-presenting B cells The Journal of Immunology 2004 172 3 1501 1507
60. Heit A., Schmitz F., Haas T., Busch D. H., Wagner H., Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity European Journal of Immunology 2007 37 8 2063 2074
61. Enioutina E. Y., Bareyan D., Daynes R. A., TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses The Journal of Immunology 2009 182 7 4296 4305
62. Enioutina E. Y., Bareyan D., Daynes R. A., TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines Vaccine 2008 26 5 601 613
63. Daynes R. A., Enioutina E. Y., Butler S., Mu H.-H., McGee Z. A., Araneo B. A., Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization Infection and Immunity 1996 64 4 1100 1109
64. Grgacic E. V. L., Anderson D. A., Virus-like particles: passport to immune recognition Methods 2006 40 1 60 65
65. Sedlik C., Saron M.-F., Sarraseca J., Casal I., Leclerc C., Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells Proceedings of the National Academy of Sciences of the United States of America 1997 94 14 7503 7508
66. Storni T., Ruedl C., Schwarz K., Schwendener R. A., Renner W. A., Bachmann M. F., Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects The Journal of Immunology 2004 172 3 1777 1785
67. Leclerc D., Beauseigle D., Denis J., Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells Journal of Virology 2007 81 3 1319 1326
68. Fausch S. C., Da Silva D. M., Kast W. M., Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells Cancer Research 2003 63 13 3478 3482
69. Ruedl C., Storni T., Lechner F., Bachi T., Bachmann M. F., Cross-presentation of virus-like particles by skin-derived CD 8- dendritic cells: a dispensable role for TAP European Journal of Immunology 2002 32 3 818 825
70. Paliard X., Liu Y., Wagner R., Wolf H., Baenziger J., Walker C. M., Priming of strong, broad, and long-lived HIV type 1 p55(gag)-specific CD 8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques AIDS Research and Human Retroviruses 2000 16 3 273 282
71. Lacasse P., Denis J., Lapointe R., Leclerc D., Lamarre A., Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation Journal of Virology 2008 82 2 785 794
72. Moron V. G., Rueda P., Sedlik C., Leclerc C., In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway The Journal of Immunology 2003 171 5 2242 2250
73. Bohm W., Schirmbeck R., Elbe A., Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo The Journal of Immunology 1995 155 7 3313 3321
74. Di Bonito P., Grasso F., Mochi S., Anti-tumor CD 8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein Virology 2009 395 1 45 55
75. Krishnamachari Y., Salem A. K., Innovative strategies for co-delivering antigens and CpG oligonucleotides Advanced Drug Delivery Reviews 2009 61 3 205 217
76. Singh M., O'Hagan D. T., Recent advances in vaccine adjuvants Pharmaceutical Research 2002 19 6 715 728
77. Zhang X.-Q., Dahle C. E., Baman N. K., Rich N., Weiner G. J., Salem A. K., Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles Journal of Immunotherapy 2007 30 5 469 478
78. Keegan M. E., Saltzman W. M., Surface-modified biodegradable microspheres for DNA vaccine delivery Methods in Molecular Medicine 2006 127 107 113
79. Waeckerle-Men Y., Groettrup M., PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines Advanced Drug Delivery Reviews 2005 57 3 475 482
80. Boisgerault F., Rueda P., Sun C. M., Hervas-Stubbs S., Rojas M., Leclerc C., Cross-priming of T cell responses by synthetic microspheres carrying a CD 8+ T cell epitope requires an adjuvant signal The Journal of Immunology 2005 174 6 3432 3439
81. Bennett S. R. M., Carbone F. R., Karamalis F., Miller J. F. A. P., Heath W. R., Induction of a CD 8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD 4+ T cell help Journal of Experimental Medicine 1997 186 1 65 70
82. Bennett S. R. M., Carbone F. R., Karamalis F., Flavell R. A., Miller J. F. A. P., Heath W. R., Help for cytotoxic-T-cell responses is mediated by CD4O signalling Nature 1998 393 6684 478 480
83. Waeckerle-Men Y., Scandella E., Uetz-Von Allmen E., Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy Journal of Immunological Methods 2004 287 1-2 109 124
84. Schlosser E., Mueller M., Fischer S., TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses Vaccine 2008 26 13 1626 1637
85. Krishnan L., Gurnani K., Dicaire C. J., Rapid clonal expansion and prolonged maintenance of memory CD 8+ T cells of the effector (CD44high CD62Llow) and central (CD44high CD62Llow) phenotype by an archaeosome adjuvant independent of TLR2 The Journal of Immunology 2007 178 4 2396 2406
86. Busch D. H., Pilip I. M., Vijh S., Pamer E. G., Coordinate regulation of complex T cell populations responding to bacterial infection Immunity 1998 8 3 353 362
87. Badiee A., Davies N., McDonald K., Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205 Vaccine 2007 25 25 4757 4766
88. Badiee A., Jaafari M. R., Khamesipour A., Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes Experimental Parasitology 2007 115 2 127 134
89. Krishnan L., Sprott G. D., Archaeosome adjuvants: immunological capabilities and mechanism(s) of action Vaccine 2008 26 17 2043 2055
90. Krishnan L., Dicaire C. J., Patel G. B., Sprott G. D., Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum Infection and Immunity 2000 68 1 54 63
91. Gurnani K., Kennedy J., Sad S., Sprott G. D., Krishnan L., Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing The Journal of Immunology 2004 173 1 566 578
92. Krishnan L., Sad S., Patel G. B., Sprott G. D., Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge Cancer Research 2003 63 10 2526 2534
93. Krishnan L., Sad S., Patel G. B., Sprott G. D., Archaeosomes induce long-term CD 8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD 4+ T cell help The Journal of Immunology 2000 165 9 5177 5185